SCHEMBL2069141

SCHEMBL2069141

COC(=O)c1cccc(N2CCCC(CO)C2)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
KDM4E B2RXH2 3/20 0.52
MEN1 O00255 2/20 0.52
PPARA Q07869 3/20 0.49
GAA P10253 2/20 0.46
GRM2 Q14416 1/20 0.45
ALDH1A1 P00352 3/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TP53 P04637 1/20 0.43
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
MAPT P10636 1/20 0.42
PKM P14618 1/20 0.42
ALOX15 P16050 1/20 0.42
HTR7 P34969 1/20 0.42
CASR P41180 1/20 0.42
PTGER4 P35408 1/20 0.42
RHOA P61586 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2070213 0.89 BPTF (0.49) KMT2AKDM4EMEN1PPARAGAA
SCHEMBL15630696 0.84 ALDH1A1 (0.50) KMT2AKDM4EMEN1GAAGRM2
SCHEMBL2070008 0.83 DPP4 (0.51) KMT2AKDM4EMEN1GAAGRM2
SCHEMBL15630772 0.83 DPP4 (0.51) KMT2AKDM4EMEN1GAAGRM2
SCHEMBL2069796 0.83 MAPK1 (0.49) KMT2APPARAGAAGRM2ALDH1A1
SCHEMBL2070351 0.82 NOTUM (0.56) KMT2AKDM4EMEN1PPARAGAA
Hydrochloric Acid SCHEMBL28486757 0.81 BPTF (0.56) KMT2AKDM4EMEN1PPARAGAA
SCHEMBL2069664 0.81 PPARA (0.50) PPARARHOA
SCHEMBL5743752 0.80 ALDH1A1 (0.66) KMT2AKDM4EMEN1GAAALDH1A1
SCHEMBL4203044 0.79 ALDH1A1 (0.64) KMT2AKDM4EMEN1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
CN-101014595-A Novel cyclic aminobenzoic acid derivative KYORIN SEIYAKU KK (JP) 2007-08-08 CN disclosed
EP-1780210-A1 NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE Kyorin Pharmaceutical Co., Ltd. (JP) 2007-05-02 EP disclosed
EP-1780210-A1 NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE Kyorin Pharmaceutical Co., Ltd. (JP) 2007-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative PPARA, PPARG, PPARD KMT2A 557/4885KDM4E 1797/4885MEN1 3887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.